Literature DB >> 10678993

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

J Turner1, E R Rhoades, M Keen, J T Belisle, A A Frank, I M Orme.   

Abstract

Two vaccine formulations previously shown to induce protective immunity in mice and prevention of long-term necrosis in guinea pigs were tested as potential immunotherapeutic vaccines in mice earlier infected by aerosol with Mycobacterium tuberculosis. Neither vaccine had any effect on the course of the infection in the lungs, but both reduced the bacterial load in the spleen. Similarly, inoculation with Mycobacterium bovis BCG had no effect whatsoever and, if given more than once, appeared to induce an increasingly severe pyogranulomatous response in the lungs of these mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678993      PMCID: PMC97334          DOI: 10.1128/IAI.68.3.1706-1709.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  Progress in the development of new vaccines against tuberculosis.

Authors:  I M Orme
Journal:  Int J Tuberc Lung Dis       Date:  1997-04       Impact factor: 2.373

2.  Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.

Authors:  J T Belisle; V D Vissa; T Sievert; K Takayama; P J Brennan; G S Besra
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

3.  An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis.

Authors:  C D D'Souza; A M Cooper; A A Frank; R J Mazzaccaro; B R Bloom; I M Orme
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

4.  Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.

Authors:  S L Baldwin; C D'Souza; A D Roberts; B P Kelly; A A Frank; M A Lui; J B Ulmer; K Huygen; D M McMurray; I M Orme
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 5.  New vaccines against tuberculosis. The status of current research.

Authors:  I M Orme
Journal:  Infect Dis Clin North Am       Date:  1999-03       Impact factor: 5.982

6.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Authors:  K Huygen; J Content; O Denis; D L Montgomery; A M Yawman; R R Deck; C M DeWitt; I M Orme; S Baldwin; C D'Souza; A Drowart; E Lozes; P Vandenbussche; J P Van Vooren; M A Liu; J B Ulmer
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  Antimycobacterial activity in vivo of LM427 (rifabutin).

Authors:  I M Orme
Journal:  Am Rev Respir Dis       Date:  1988-11

8.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection.

Authors:  P J Murray; L Wang; C Onufryk; R I Tepper; R A Young
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

9.  Does the efficacy of BCG decline with time since vaccination?

Authors:  J A Sterne; L C Rodrigues; I N Guedes
Journal:  Int J Tuberc Lung Dis       Date:  1998-03       Impact factor: 2.373

10.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

View more
  27 in total

Review 1.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection.

Authors:  Gillian L Beamer; Joshua Cyktor; David K Flaherty; Paul C Stromberg; Bridget Carruthers; Joanne Turner
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

Review 3.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

4.  Immunization with Mycobacterium tuberculosis-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in Mice.

Authors:  Claus Aagaard; Niels Peter Hell Knudsen; Iben Sohn; Angelo A Izzo; Hongmin Kim; Emma Holsey Kristiansen; Thomas Lindenstrøm; Else Marie Agger; Michael Rasmussen; Sung Jae Shin; Ida Rosenkrands; Peter Andersen; Rasmus Mortensen
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

5.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.

Authors:  Andrea Cruz; Alexandra G Fraga; Jeffrey J Fountain; Javier Rangel-Moreno; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Troy D Randall; Jorge Pedrosa; Andrea M Cooper; António G Castro
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

6.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

7.  Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.

Authors:  Samantha L Sampson; Christopher C Dascher; Vasan K Sambandamurthy; Robert G Russell; William R Jacobs; Barry R Bloom; Mary K Hondalus
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

Authors:  B M Buddle; D N Wedlock; N A Parlane; L A L Corner; G W De Lisle; M A Skinner
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Induction of a specific strong polyantigenic cellular immune response after short-term chemotherapy controls bacillary reactivation in murine and guinea pig experimental models of tuberculosis.

Authors:  Evelyn Guirado; Olga Gil; Neus Cáceres; Mahavir Singh; Cristina Vilaplana; Pere-Joan Cardona
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

10.  Post-exposure vaccination against Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Gopinath S Palaniswamy; Erin E Smith; Crystal A Shanley; Baolin Wang; Ian M Orme; Randall J Basaraba; Nancy M DuTeau; Diane Ordway
Journal:  Tuberculosis (Edinb)       Date:  2009-03-04       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.